Panadol Osteo ban urged for overdose problems

The TGA is reviewing the availability of over-the-counter, sustained-release paracetamol products, such as Pandol Osteo, following an EU move to ban them because of problems with managing overdose.

A European Medicines Agency (EMA) committee has recommended that 665mg sustained-release paracetamol be withdrawn from sale after clinicians raised concerns about difficulties in treating patients who had taken overdoses of the long-acting analgesics.

“Experience has shown that